Sort
21,281 grants matching “influenza”
Role of T Regulatory Cells in Chronic Infection
$243,100Ethan Shevach · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Glycoconjugates in viral pathogenesis
$243,090Gillian M. Air · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2007 · AI
Mechanism of Synaptic SNARE Assembly
$243,076Iowa State University · R01 · FY2004 · GM
Generation of effective memory CD8 T cells to influenza
$243,054Troy D Randall · Trudeau Institute, Inc. · R01 · FY2008 · AI
Mechanism of Synaptic SNARE Assembly
$243,009Iowa State University · R01 · FY2005 · GM
Promoting Health, Safety, and Recovery Training for COVID-19 Essential Workers and their Communities
$243,004David Turcotte · University Of Massachusetts Lowell · U45 · FY2021 · ES
Vaccines as drivers of disease emergence: transmission ecology and virulence evol
$243,003Andrew F. Read · Pennsylvania State University, The · R01 · FY2014 · GM
Age and testosterone effects on responses to influenza infection and vaccination
$243,000Sabra L Klein · Johns Hopkins University · R21 · FY2014 · AI
A VSV vectored vaccine for emergent tick-born phleboviruses
$243,000Paul F Bates · University Of Pennsylvania · R21 · FY2020 · AI
A Totally Synthetic Immunostimulator that Targets Toll-like Receptor 2 and NOD2: Toward Improved Influenza Vaccines
$243,000Larry C. Blaszczak · Teichos Laboratories, Llc · R43 · FY2021 · IP
Identification of Serodiagnostic Epitopes for SARS-CoV-2, endemic HCoV?s and influenza virus
$243,000David Camerini · Immport Therapeutics, Inc. · R43 · FY2021 · IP
Structural basis of antibody affinity maturation by somatic hypermutation
$243,000Zizhang Sheng · Columbia University Health Sciences · R21 · FY2019 · AI
Tuft Cells Modulate Macrophage Response Following Lung Viral Infection
$243,000Jianwen Que · Columbia University Health Sciences · R21 · FY2022 · AI
Control of type I interferon responses by p53
$243,000Fred Bunz · Johns Hopkins University · R21 · FY2016 · AI
A killed whole-cell one dose cholera vaccine
$243,000William Franklin Wade · Dartmouth College · R21 · FY2016 · AI
Development of Antigen-based Vertical Flow Assay for the Rapid Detection of SARS-CoV-2, Influenza A/B, and RSV
$243,000Arunkumar Arumugam · Ai Biosciences, Inc. · R43 · FY2021 · IP
The role of TAX1BP1 in the innate immune response to virus infection
$243,000Edward W Harhaj · Johns Hopkins University · R21 · FY2015 · AI
Rapid mass production of human influenza vaccine in insects using genome editing
$243,000Virginia Emery · Beta Hatch Inc. · R43 · FY2021 · IP
Molecular Mechanisms of HLA-DO in Antigen Processing
$243,000Scheherazade Sadegh-Nasseri · Johns Hopkins University · R21 · FY2012 · AI
Feasibility of Alcohol and Tobacco Use Surveillance via Personal Health Records
$242,938Elissa R Weitzman · Boston Children'S Hospital · R21 · FY2007 · AA
The NS1 and M Genes of the 1918 Influenza Virus
$242,938Mount Sinai School Of Medicine Of Nyu · P01 · FY2004 · AI
4-Aminopiperidines as novel anti-influenza agents
$242,913Lijun Rong · Chicago Biosolutions, Inc. · R41 · FY2016 · AI
Monoclonal Antibody Core
$242,911Patrick Christopher Wilson · Icahn School Of Medicine At Mount Sinai · U19 · FY2014 · AI
Sample Sparing By Miniaturizing and Simultaneous Multiplexing an ELISA Immunoassay
$242,883Grace Bio-Labs, Inc. · N01 · FY2018 · AI
Addressing Racial Disparities in Influenza Prevention
$242,840Kenzie A Cameron · Northwestern University At Chicago · K01 · FY2006 · CD